Literature DB >> 33851314

Minimal ovarian stimulation is an alternative to conventional protocols for older women according to Poseidon's stratification: a retrospective multicenter cohort study.

Mauro Cozzolino1,2,3, Gustavo Nardini Cecchino4,5,6, Ernesto Bosch7, Juan Antonio Garcia-Velasco8,4,9, Nicolás Garrido8.   

Abstract

OBJECTIVE: To investigate whether minimal ovarian stimulation (mOS) is as effective as conventional ovarian stimulation (cOS) for older women belonging to different groups according to the Poseidon criteria.
MATERIAL AND METHODS: Observational retrospective multicentre cohort including women from Poseidon's groups 2 and 4 that underwent in vitro fertilization (IVF). We performed a mixed-effects logistic regression model, adding as a random effect the patients and the stimulation cycle considering the dependence of data. Survival curves were employed as a measure of the cumulative live birth rate (CLBR). The primary outcomes were live birth rate per embryo transfer and CLBR per consecutive embryo transfer and oocyte consumed until a live birth was achieved.
RESULTS: A total of 2002 patients underwent 3056 embryo transfers (mOS = 497 and cOS = 2559). The live birth rates per embryo transfer in mOS and cOS showed no significant difference in both Poseidon's groups. Likewise, the logistic regression showed similar live birth rates between the two protocols in Poseidon's groups 2 (OR 1.165, 95% CI 0.77-1.77; p = 0.710) and 4 (OR 1.264 95% CI 0.59-2.70; p = 0.387). However, the survival curves showed higher CLBR per oocyte in women that received mOS (Poseidon group 2: p < 0.001 and Poseidon group 4: p = 0.039).
CONCLUSIONS: Minimal ovarian stimulation is a good alternative to COS as a first-line treatment for patients belonging to Poseidon's groups 2 and 4. The number of oocytes needed to achieve a live birth seems inferior in mOS strategy than cOS.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  In vitro fertilization; Live birth; Minimal ovarian stimulation; Poor responders; Poseidon

Mesh:

Substances:

Year:  2021        PMID: 33851314      PMCID: PMC8324662          DOI: 10.1007/s10815-021-02185-2

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.357


  40 in total

1.  Conventional versus minimal ovarian stimulation: an intra-patient comparison of ovarian response in poor-responder women according to Bologna Criteria.

Authors:  Elena Labarta; Diego Marin; José Remohí; Ernesto Bosch
Journal:  Reprod Biomed Online       Date:  2018-08-23       Impact factor: 3.828

2.  The Bologna criteria for poor ovarian response: the good, the bad and the way forward.

Authors:  Christos A Venetis
Journal:  Hum Reprod       Date:  2014-06-07       Impact factor: 6.918

3.  Mild versus conventional ovarian stimulation for IVF in poor responders: a systematic review and meta-analysis.

Authors:  Adrija Kumar Datta; Abha Maheshwari; Nirmal Felix; Stuart Campbell; Geeta Nargund
Journal:  Reprod Biomed Online       Date:  2020-03-14       Impact factor: 3.828

4.  Economic impact of ovarian stimulation with corifollitropin alfa versus conventional daily gonadotropins in oocyte donors: a randomized study.

Authors:  María Cruz; Pilar Alamá; Manuel Muñoz; Diana Collado; Carlos Blanes; Enrique Solbes; Antonio Requena
Journal:  Reprod Biomed Online       Date:  2017-03-14       Impact factor: 3.828

Review 5.  What is new in the management of poor ovarian response in IVF?

Authors:  Alberto Vaiarelli; Danilo Cimadomo; Nicolò Ubaldi; Laura Rienzi; Filippo Maria Ubaldi
Journal:  Curr Opin Obstet Gynecol       Date:  2018-06       Impact factor: 1.927

6.  The ISMAAR proposal on terminology for ovarian stimulation for IVF.

Authors:  G Nargund; B C J M Fauser; N S Macklon; W Ombelet; K Nygren; R Frydman
Journal:  Hum Reprod       Date:  2007-09-12       Impact factor: 6.918

7.  "Mild" vs. "long" protocol for controlled ovarian hyperstimulation in patients with expected poor ovarian responsiveness undergoing in vitro fertilization (IVF): a large prospective randomized trial.

Authors:  Alberto Revelli; Alessandra Chiadò; Paola Dalmasso; Veronica Stabile; Francesca Evangelista; Gemma Basso; Chiara Benedetto
Journal:  J Assist Reprod Genet       Date:  2014-04-04       Impact factor: 3.412

8.  Individualized versus standard FSH dosing in women starting IVF/ICSI: an RCT. Part 1: The predicted poor responder.

Authors:  Theodora C van Tilborg; Helen L Torrance; Simone C Oudshoorn; Marinus J C Eijkemans; Carolien A M Koks; Harold R Verhoeve; Annemiek W Nap; Gabrielle J Scheffer; A Petra Manger; Benedictus C Schoot; Alexander V Sluijmer; Arie Verhoeff; Henk Groen; Joop S E Laven; Ben Willem J Mol; Frank J M Broekmans
Journal:  Hum Reprod       Date:  2017-12-01       Impact factor: 6.918

Review 9.  Management of poor responders in IVF: is there anything new?

Authors:  Filippo Ubaldi; Alberto Vaiarelli; Rosario D'Anna; Laura Rienzi
Journal:  Biomed Res Int       Date:  2014-07-20       Impact factor: 3.411

10.  Comparison Pregnancy Outcomes Between Minimal Stimulation Protocol and Conventional GnRH Antagonist Protocols in Poor Ovarian Responders.

Authors:  Shamim Pilehvari; Ensieh ShahrokhTehraninejad; Batool Hosseinrashidi; Fatemeh Keikhah; Fedyeh Haghollahi; Elham Aziminekoo
Journal:  J Family Reprod Health       Date:  2016-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.